Clinical Trial Update: Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BAY 1817080 including repeat dosing in healthy males and proof-of-concept in chronic cough patients (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• BAY 1817080

Snippet

Sponsor: Bayer | Conditions: Cough | Phase 1, Phase 2 | Status: COMPLETED